Armaceutica, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML) (NCT05291390) | Armaceutica, Inc. | 2022-11-21 |
Track Armaceutica, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.